www.statnews.com
Open in
urlscan Pro
2606:4700::6812:1ccd
Public Scan
Submitted URL: http://www.statnews.com/
Effective URL: https://www.statnews.com/
Submission: On January 18 via api from US — Scanned from DE
Effective URL: https://www.statnews.com/
Submission: On January 18 via api from US — Scanned from DE
Form analysis
4 forms found in the DOMGET https://www.statnews.com/
<form class="header-search search-form" role="search" method="get" action="https://www.statnews.com/">
<input type="search" class="search-form-field" placeholder="Search …" value="" name="s" aria-label="Search …">
<button type="submit" class="header-btn header-btn-search">Search</button>
</form>
Name: page — POST /wp-json/stat-hubspot/v1/signup
<form class="stat-hubspot-signup stat-form" method="post" action="/wp-json/stat-hubspot/v1/signup" name="page">
<div class="stat-hubspot-signup-fields">
<div class="stat-form-inline" data-stat-newsletter-no-step-2="">
<div class="stat-form-full">
<input type="email" name="email" placeholder="Email Address" aria-label="Enter your email" required="">
<div class="stat-field-error">Please enter a valid email address.</div>
<input type="submit" value="Sign Up">
<input type="hidden" name="stat_newsletters_source" value="homepage_widget">
<input type="hidden" name="lists[stat_newsletters]" value="morning_rounds">
</div>
<div class="stat-form-full stat-form-checkbox-wrapper">
<input type="checkbox" name="marketing_opt_in" id="marketing" value="1">
<label for="marketing">I'd like to be emailed about new content, events, and products.</label>
</div>
</div>
</div>
<div class="stat-hubspot-signup-response"></div>
</form>
Name: modal — POST /wp-json/stat-hubspot/v1/signup
<form class="stat-hubspot-signup stat-form" method="post" action="/wp-json/stat-hubspot/v1/signup" name="modal">
<div class="stat-hubspot-signup-fields">
<div class="stat-form-full">
<div class="stat-form-brand">
<img loading="lazy" decoding="async" src="https://www.statnews.com/wp-content/uploads/2023/06/Morning-Rounds-Logo-Black.png" alt="Morning Rounds" class="stat-form-brand-logo" width="700" height="323">
<p class="stat-form-brand-description">Understand how science, health policy, and medicine shape the world every day</p>
</div>
<input type="email" name="email" required="" placeholder="Email Address">
<div class="stat-form-select-wrapper">
<select name="industry_internal_" class="has-faux-placeholder is-empty" aria-label="Industry">
<option value="" selected="">Industry</option>
<option value="Academia">Academia</option>
<option value="Advertising/Communications Agency">Advertising/Communications Agency</option>
<option value="Advocacy/Non-Profit">Advocacy/Non-Profit</option>
<option value="Banking">Banking</option>
<option value="Biotech">Biotech</option>
<option value="Clinical Research Organization">Clinical Research Organization</option>
<option value="Consulting Firm">Consulting Firm</option>
<option value="Consumer Health">Consumer Health</option>
<option value="Financial Services (Other)">Financial Services (Other)</option>
<option value="Government">Government</option>
<option value="Healthcare Payer/Insurance">Healthcare Payer/Insurance</option>
<option value="Health Tech">Health Tech</option>
<option value="Hospital Systems/Provider">Hospital Systems/Provider</option>
<option value="Law">Law</option>
<option value="Media">Media</option>
<option value="Medical Devices">Medical Devices</option>
<option value="Medical Technology">Medical Technology</option>
<option value="Pharmaceuticals">Pharmaceuticals</option>
<option value="Pharmacy/Retail">Pharmacy/Retail</option>
<option value="Real Estate">Real Estate</option>
<option value="Trade Association">Trade Association</option>
<option value="Technology">Technology</option>
<option value="Venture Capital">Venture Capital</option>
</select>
</div>
<input type="submit" class="stat-button-primary" value="Sign up for our newsletter">
<span class="privacy-link"><a href="/privacy/" target="_blank" rel="noopener noreferrer">Privacy Policy</a></span>
<input type="hidden" name="stat_newsletters_source" value="bc_modal">
<input type="hidden" name="stat_newsletters_campaign" value="">
<input type="hidden" name="lists[stat_newsletters]" value="morning_rounds">
</div>
</div>
<div class="stat-hubspot-signup-response"></div>
</form>
Name: default — POST /wp-json/stat-hubspot/v1/signup
<form class="stat-hubspot-signup stat-form" method="post" action="/wp-json/stat-hubspot/v1/signup" name="default">
<div class="stat-hubspot-signup-fields">
<input type="email" name="email" placeholder="Enter your email" aria-label="Enter your email" required="">
<button class="stat-arrow-submit" aria-label="Submit">
<span class="far fa-arrow-right" aria-hidden="true"></span>
</button>
<input type="hidden" name="stat_newsletters_source" value="footer_bar">
<input type="hidden" name="stat_newsletters_campaign" value="">
<input type="hidden" name="lists[stat_newsletters]" value="morning_rounds">
</div>
<div class="stat-hubspot-signup-response"></div>
</form>
Text Content
Skip to Main Content Explore what it takes to make the health care system work. research Hospitals Congress STAT Madness: Apply now to be the next MVP of health & medicine * Newsletters * Log In * My Account * Subscribe Now My Account * Settings * Billing * Log In Reporting from the frontiers of health and medicine * Newsletters * Log In * My Account * Subscribe Now * Biotech * Pharma * Public Health * Health Tech * Policy * Science * First Opinion * STAT+ * STAT Events * Search * Log In * Subscribe Now * My Account Home News * Latest * Business * Biotech * Pharma * Health Tech * Health Insurance * Hospitals * Medical Devices * Washington * Policy * FDA * CDC * NIH * Science * CRISPR * Gene Therapy * Research * Neuroscience * Public Health * Addiction * Covid-19 * Abortion * Health Disparities * Infectious Disease * Mental Health * Disease * Cancer * Cardiovascular Disease * Chronic Disease * Diabetes * Dementia * Obesity * Features * The Obesity Revolution * Living With * Death Sentence Newsletters Opinion Columns * Adam Feuerstein * Matthew Herper * Jennifer Adaeze Okwerekwu * Ed Silverman Podcasts Video Tools & Trackers * STAT Trials Pulse * CRISPR Trackr * Breakthrough Device Tracker * Generative AI Tracker * Obesity Drug Tracker Events * Breakthrough Summit East * All Events Community * STAT+ Connect * Wunderkinds Reports E-Books Don't miss out Subscribe to STAT+ today, for the best life sciences journalism in the industry Learn more STAT — REPORTING FROM THE FRONTIERS OF HEALTH AND MEDICINE LATEST * 15 min ago BERNIE SANDERS PROPOSES SUBPOENAS OF CEOS OF J&J, MERCK ON DRUG PRICES * 2 hr ago PIPELINES FROM HIGH SCHOOL TO HEALTH CARE JOBS TO BE CREATED BY NEW BLOOMBERG PHILANTHROPIES INITIATIVE * 5 hr ago APPLE WATCH PULSE OXIMETER FEATURE REMOVED TO COMPLY WITH BAN * * 5 hr ago THE XBI COMEDOWN AFTER JPM * 10 hr ago A NEW HHS RULE TAKES A FAR TOO NARROW APPROACH TO HEALTH CARE DATA INTEROPERABILITY * 20 hr ago CONGRESS’ NEGOTIATIONS OVER DOC PAY, HEALTH CENTERS FELL APART AHEAD OF SPENDING EXTENSION More Stories DON'T MISS Join fellow industry leaders in NYC this March for Breakthrough Summit East Learn more TOP STORIES Health PUMPING BREASTMILK IN BATHROOMS IS A COMMON, ALBEIT UNSPOKEN, PRACTICE AT HEALTH CARE CONFERENCES Nearly 100 people reached out to STAT about the difficulty of pumping breastmilk at the J.P. Morgan Healthcare Conference. By Tara Bannow 10 hr ago * JPM 2024 By Tara Bannow Health Health 31 min ago COULD LONG COVID’S SIGNS OF IMMUNE DYSREGULATION IN THE BLOOD LEAD TO A DIAGNOSTIC TEST? By Elizabeth Cooney Health Health 10 hr ago AMID A DIRE NATIONWIDE THERAPIST SHORTAGE, COULD LAY COUNSELORS HELP CLOSE THE GAP? By Grace Rubenstein Biotech Biotech 3 hr ago STAT PLUS: CRISPR-EDITED PIG LIVER FROM EGENESIS PASSES FIRST TEST IN BRAIN-DEAD HUMAN, RESEARCHERS SAY By Megan Molteni Health Tech Health Tech 10 hr ago STAT PLUS: HOW DIGITAL THERAPEUTICS COMPANIES ARE IMPROVISING WHEN INSURANCE COVERAGE ISN’T GUARANTEED By Mario Aguilar MOST READ The Readout READOUT NEWSLETTER: UPDATES ON VERTEX, KYVERNA, ELI LILLY 1 of 4 most read today Health RISKY WEIGHT LOSS PRODUCTS OFTEN USED BY TEENS GLOBALLY, PER STUDY 2 of 4 most read today First Opinion MULTISPECIALTY MEDICAL GROUPS ARE RAPIDLY LOSING THEIR INDEPENDENCE 3 of 4 most read today Health Care Inc. MEDICARE ADVANTAGE TODAY, EXPLAINED IN ONE CHART 4 of 4 most read today MOST READ IN STAT+ Politics STAT PLUS: COPAY COUPONS TO COUNT TOWARD DEDUCTIBLES, AFTER BIDEN COURT MOVE 1 of 5 most read today Insurance STAT PLUS: PRIOR AUTHORIZATION WILL HAVE TO MOVE FASTER UNDER NEW BIDEN RULE 2 of 5 most read today Exclusive STAT PLUS: CONGRESS' DOC PAY, HEALTH CENTER TALKS JUST FAILED. WHAT'S NEXT? 3 of 5 most read today Health Tech STAT PLUS: FDA CLEARS AI TOOL FOR DETECTING SKIN CANCER 4 of 5 most read today Health STAT PLUS: STUDY FINDS TESTOSTERONE TREATMENT DIDN'T LOWER FRACTURE RISK IN MEN 5 of 5 most read today SPONSORED Advertisement FIRST OPINION * First Opinion A NEW HHS RULE TAKES A FAR TOO NARROW APPROACH TO HEALTH CARE DATA INTEROPERABILITY * First Opinion THE DECLINE AND FALL OF ELITE MULTISPECIALTY MEDICAL GROUPS * * First Opinion CORD BLOOD BANKING SOUNDS LIKE A GREAT IDEA — UNTIL YOU REALIZE WHAT IT COSTS BABIES All First Opinion STAT+ YOUR GO-TO SOURCE FOR THE WORLD OF LIFE SCIENCES, MEDICINE, AND BIOPHARMA. SUBSCRIBE NOW. Cancel anytime. Subscribe now TRENDING NOW All STAT+ Stories DEWPOINT THERAPEUTICS CUTS 15% OF STAFF, ACKNOWLEDGES MERCK, PFIZER BROKE OFF PARTNERSHIPS OVER BUZZY SCIENCE FDA EXPANDS APPROVAL OF CRISPR-BASED MEDICINE TO TREAT BETA THALASSEMIA MORE PATIENTS ARE GETTING THEIR MEDS ONLINE. BIG PHARMA WANTS IN ON THE ACTION AT HEALTH CARE’S BIGGEST INVESTOR CONFERENCE, AI’S HIGH HOPES COLLIDED WITH SKEPTICISM All STAT+ Stories All Events More From STAT More From STAT More From STAT EVENTS STAT offers a variety of in-person and virtual events throughout the year. All Events 21 Mar 2024 STAT BREAKTHROUGH SUMMIT EAST New York, NY March 21, 2024 At 2024 Breakthrough Summit East, we gather industry leaders & patients to find real answers on how to make sure that science is benefiting the ones who desperately need it. All Events MORE STORIES * Latest * Most Read * Subscriber Only * Opinion * Politics Politics 15 min ago BERNIE SANDERS PROPOSES SUBPOENAS OF CEOS OF J&J, MERCK ON DRUG PRICES By Rachel Cohrs • 15 min ago Health Care Health Care 2 hr ago STAT PLUS: PIPELINES FROM HIGH SCHOOL TO HEALTH CARE JOBS TO BE CREATED BY NEW BLOOMBERG PHILANTHROPIES INITIATIVE By Christopher Huffaker — Boston Globe • 2 hr ago Health Tech Health Tech 5 hr ago STAT PLUS: APPLE WATCH PULSE OXIMETER FEATURE REMOVED TO COMPLY WITH BAN By Lizzy Lawrence • 5 hr ago The Readout The Readout 5 hr ago THE XBI COMEDOWN AFTER JPM By Damian Garde • 5 hr ago First Opinion First Opinion 10 hr ago A NEW HHS RULE TAKES A FAR TOO NARROW APPROACH TO HEALTH CARE DATA INTEROPERABILITY By John C. (Jack) Lewin and Jane Delgado • 10 hr ago Exclusive Exclusive 20 hr ago STAT PLUS: CONGRESS’ NEGOTIATIONS OVER DOC PAY, HEALTH CENTERS FELL APART AHEAD OF SPENDING EXTENSION By Rachel Cohrs • 20 hr ago Health Health 22 hr ago STAT PLUS: TESTOSTERONE DIDN’T LOWER FRACTURE RISK IN A SURPRISING NEW STUDY. RESEARCHERS HAVE THEORIES ABOUT WHY By Annalisa Merelli • 22 hr ago Insurance Insurance 22 hr ago STAT PLUS: BIDEN CHANGES WILL FORCE HEALTH INSURERS TO SPEED UP AND GET MORE SPECIFIC IF THEY WANT TO DENY CARE By Brittany Trang • 22 hr ago Politics Politics 24 hr ago STAT PLUS: COPAY COUPONS FOR SOME DRUGS MUST COUNT TOWARD DEDUCTIBLES, AFTER BIDEN COURT MOVE By John Wilkerson • 24 hr ago Health Tech Health Tech 1 day ago STAT PLUS: GENERAL CATALYST TO BUY OHIO-BASED SAFETY NET HEALTH SYSTEM SUMMA HEALTH By Mohana Ravindranath • 1 day ago The Readout The Readout 1 day ago THE BIG ANY-DAY-NOW BIOTECH NEWS WE’RE KEEPING AN EYE ON By Damian Garde • 1 day ago Health Tech Health Tech 1 day ago STAT PLUS: FDA CLEARS AI SKIN CANCER DETECTOR FOR PRIMARY CARE DOCTORS TO USE By Lizzy Lawrence • 1 day ago Pharma Pharma 1 day ago STAT PLUS: MORE PATIENTS ARE GETTING THEIR MEDS ONLINE. BIG PHARMA WANTS IN ON THE ACTION By Katie Palmer • 1 day ago All Stories Health Tech Health Tech 10 hr ago STAT PLUS: HOW DIGITAL THERAPEUTICS COMPANIES ARE IMPROVISING WHEN INSURANCE COVERAGE ISN’T GUARANTEED By Mario Aguilar • 10 hr ago Health Tech Health Tech 1 day ago STAT PLUS: AT HEALTH CARE’S BIGGEST INVESTOR CONFERENCE, AI’S HIGH HOPES COLLIDED WITH SKEPTICISM By Casey Ross, Matthew Herper, and Mohana Ravindranath • 1 day ago Pharma Pharma 1 day ago STAT PLUS: MORE PATIENTS ARE GETTING THEIR MEDS ONLINE. BIG PHARMA WANTS IN ON THE ACTION By Katie Palmer • 1 day ago Health Health 10 hr ago AMID A DIRE NATIONWIDE THERAPIST SHORTAGE, COULD LAY COUNSELORS HELP CLOSE THE GAP? By Grace Rubenstein • 10 hr ago Politics Politics 15 min ago BERNIE SANDERS PROPOSES SUBPOENAS OF CEOS OF J&J, MERCK ON DRUG PRICES By Rachel Cohrs • 15 min ago First Opinion First Opinion 1 week ago PUMPING MILK AT JPM WAS A NIGHTMARE. IT’S PART OF A BIGGER PROBLEM IN THE INDUSTRY By Tara Bannow • 1 week ago Pharmalot Pharmalot 5 hr ago STAT PLUS: PHARMALITTLE: WE’RE READING ABOUT DRUG PRICE HIKES, BAYER STRATEGIC MOVES, AND MORE By Ed Silverman • 5 hr ago Pharmalot Pharmalot 1 day ago STAT PLUS: PHARMALITTLE: WE’RE READING ABOUT A CRISPR APPROVAL, SELLING MEDS DIRECTLY TO PATIENTS, AND MORE By Ed Silverman • 1 day ago In the Lab In the Lab 1 day ago STAT PLUS: HAIR LOSS IS ONE OF THE MOST HATED CHEMOTHERAPY SIDE EFFECTS. A NEW BIOTECH HOPES TO PREVENT IT By Angus Chen • 1 day ago Health Tech Health Tech 1 day ago STAT PLUS: AT HEALTH CARE’S BIGGEST INVESTOR CONFERENCE, AI’S HIGH HOPES COLLIDED WITH SKEPTICISM By Casey Ross, Matthew Herper, and Mohana Ravindranath • 1 day ago Exclusive Exclusive 2 days ago STAT PLUS: DEWPOINT THERAPEUTICS CUTS 15% OF STAFF, ACKNOWLEDGES MERCK, PFIZER BROKE OFF PARTNERSHIPS OVER BUZZY SCIENCE By Jason Mast • 2 days ago Biotech Biotech 2 days ago STAT PLUS: FDA EXPANDS APPROVAL OF CRISPR-BASED MEDICINE TO TREAT BETA THALASSEMIA By Adam Feuerstein • 2 days ago First Opinion First Opinion 2 days ago BMI AS A BARRIER TO ORTHOPEDIC SURGERY DOESN’T MAKE SENSE FOR PATIENT HEALTH By Jody Dushay • 2 days ago Letters to the editor Letters to the editor 5 days ago WHAT STAT READERS THINK ABOUT JPM’S LOCKED LACTATION ROOM, COVERING WEIGHT LOSS DRUGS, AND MORE By Torie Bosch • 5 days ago First Opinion First Opinion 6 days ago THE NURSING STAFFING CRISIS HAS HIT ONE ROLE PARTICULARLY HARD: THE NURSE MANAGER By Toby Bressler and Lauren Ghazal • 6 days ago First Opinion First Opinion 1 week ago PUMPING MILK AT JPM WAS A NIGHTMARE. IT’S PART OF A BIGGER PROBLEM IN THE INDUSTRY By Tara Bannow • 1 week ago First Opinion First Opinion 1 week ago ADDRESSING THE BLACK YOUTH SUICIDE CRISIS REQUIRES A NEW APPROACH TO LICENSING CLINICAL SOCIAL WORKERS By Janelle Goodwill • 1 week ago First Opinion First Opinion 1 week ago HOW TO ENSURE THE NIH’S DECISION TO RECOGNIZE PEOPLE WITH DISABILITIES AS A HEALTH DISPARITY POPULATION MAKES A DIFFERENCE By Lynne Moronski • 1 week ago NEWSLETTERS Mon - Fri Your daily dose of news in health and science Elizabeth Cooney Please enter a valid email address. I'd like to be emailed about new content, events, and products. Our Picks Our Picks OUR PICKS STAT’s selection of must-read stories and investigations AS SHE DRIVES RESEARCH ON STRUCTURAL RACISM IN HEALTH CARE, RACHEL HARDEMAN FACES A PAINFUL RECKONING By Usha Lee McFarling PUMPING MILK AT JPM WAS A NIGHTMARE. IT’S PART OF A BIGGER PROBLEM IN THE INDUSTRY By Tara Bannow HHS’S XAVIER BECERRA, ONCE AN ‘INVISIBLE’ SECRETARY, IS RACING TO CEMENT A CLEARER LEGACY By Sarah Owermohle STAT PLUS: ADVOCATES EXPECT SUPREME COURT IDAHO ABORTION DECISION TO FUEL EFFORTS TO FURTHER RESTRICT ACCESS By Olivia Goldhill and Annalisa Merelli STAT PLUS: DOUDNA INSTITUTE HATCHES PLAN TO ‘CURE HUNDREDS OF DISEASES’ LEFT BEHIND BY CRISPR REVOLUTION By Jason Mast STAT PLUS: A BIOTECH REPORTER’S NOTEBOOK: SUNSHINE RAINS DOWN ON SAN FRANCISCO By Allison DeAngelis NEW YORK’S NEW DOULA PLAN WILL COVER SERVICES FOR ANYONE ON MEDICAID By Anika Nayak STAT PLUS: TEXAS TAXPAYERS WANTED TO HELP THE POOR GET HEALTH CARE. INSTEAD, THEY’RE FUNDING A MEDICAL SCHOOL AT A WEALTHY UNIVERSITY By Rachel Cohrs BIOTECH Biotech STAT PLUS: FOR-PROFIT BIOMEDICAL INSTITUTE, BACKED BY BILLIONAIRES, LAUNCHES IN CAMBRIDGE TO SPEED DRUG DISCOVERY By Robert Weisman and Jonathan Saltzman — The Boston Globe 5 days ago By Robert Weisman and Jonathan Saltzman — The Boston Globe Biotech Biotech 5 days ago STAT PLUS: FOR-PROFIT BIOMEDICAL INSTITUTE, BACKED BY BILLIONAIRES, LAUNCHES IN CAMBRIDGE TO SPEED DRUG DISCOVERY Biotech Biotech 1 week ago STAT PLUS: AT JPM, VERVE DETAILS PLOT TO TAKE GENOME EDITING MAINSTREAM Biotech Biotech 1 week ago STAT PLUS: NVIDIA SAYS A BIOLOGICAL REVOLUTION IS HAPPENING NOW. BUT IS IT? PHARMA Pharmalot STAT PLUS: SURVEY: CONFUSION OVER KEY REQUIREMENTS MEANS CLINICAL TRIALS AREN’T REGISTERED AND RESULTS AREN’T REPORTED By Ed Silverman 2 days ago By Ed Silverman Pharmalot Pharmalot 2 days ago STAT PLUS: SURVEY: CONFUSION OVER KEY REQUIREMENTS MEANS CLINICAL TRIALS AREN’T REGISTERED AND RESULTS AREN’T REPORTED Pharmalot Pharmalot 2 days ago STAT PLUS: PHARMALITTLE: WE’RE READING ABOUT WEGOVY SHIPMENTS, THE NIH DIRECTOR’S PLANS, AND MORE Pharmalot Pharmalot 6 days ago STAT PLUS: NEW CONGRESSIONAL BILL WOULD THWART PATENT THICKETS IN ORDER TO SPEED GENERIC DRUGS TO MARKET HEALTH Health THE WHO AND DRUG REGULATORS WANT TO REFORMULATE THE FLU VACCINE. IT’S EASIER SAID THAN DONE By Helen Branswell 2 days ago By Helen Branswell Health Health 2 days ago THE WHO AND DRUG REGULATORS WANT TO REFORMULATE THE FLU VACCINE. IT’S EASIER SAID THAN DONE Health Health 7 days ago IN PARTIAL REVERSAL, TEXAS MEDICAID GREENLIGHTS FIRST STEP IN GENE THERAPY FOR AFGHAN REFUGEES’ INFANT SON Health Health 1 week ago GLP-1 DRUGS NOT LINKED TO SUICIDAL THOUGHTS IN FDA’S EARLY REVIEW POLITICS Politics STAT PLUS: THE NEW NIH DIRECTOR IS WALKING A TIGHTROPE ON BIDEN’S DRUG PRICING VISION By Sarah Owermohle 2 days ago By Sarah Owermohle Politics Politics 2 days ago STAT PLUS: THE NEW NIH DIRECTOR IS WALKING A TIGHTROPE ON BIDEN’S DRUG PRICING VISION Politics Politics 1 week ago STAT PLUS: COURTS WILL DECIDE THE FUTURE OF MEDICARE’S POWER TO NEGOTIATE DRUG PRICES WITHIN MONTHS Politics Politics 1 week ago AFTER GRILLING FAUCI ON COVID ORIGINS, HOUSE REPUBLICANS WANT TO CONSIDER NEW RULES FOR FOREIGN RESEARCH VIDEO A STAT Documentary TREATING RURAL AMERICA: THE TELEHEALTH SOLUTION STAT Wunderkinds A CONVERSATION WITH THE 2023 STAT WUNDERKINDS A STAT Documentary TREATING RURAL AMERICA: THE NEW COUNTRY DOCTORS A STAT Documentary TREATING RURAL AMERICA: THE LAST DOCTOR IN TOWN All Videos special report special report One day, we woke up and found out that the health care money was being diverted from the folks who it was intended to go to.Read the story — Nelson Linder, president of the Austin, Texas, NAACP chapter special report HEALTH TECH Health Tech A NEW, NON-INVASIVE TEST COULD HELP PREDICT THE QUALITY OF EMBRYO USED FOR IVF By Deborah Balthazar 1 day ago By Deborah Balthazar Health Tech Health Tech 1 day ago A NEW, NON-INVASIVE TEST COULD HELP PREDICT THE QUALITY OF EMBRYO USED FOR IVF Health Tech Health Tech 2 days ago STAT PLUS: MANY DOCTORS ARE IN THE DARK ABOUT HOW FDA APPROVES DEVICES AND DRUGS, SURVEY FINDS Health Tech Health Tech 1 week ago STAT PLUS: RUNE LABS, WHICH MAKES AN APP TO TRACK PARKINSON’S SYMPTOMS, RAISES $12 MILLION IN THE LAB In the Lab ALLEN INSTITUTE CEO RUI COSTA ON MAPPING THE BRAIN AND PAYING EARLY-CAREER SCIENTISTS DECENT SALARIES By Jonathan Wosen 2 weeks ago By Jonathan Wosen In the Lab In the Lab 2 weeks ago ALLEN INSTITUTE CEO RUI COSTA ON MAPPING THE BRAIN AND PAYING EARLY-CAREER SCIENTISTS DECENT SALARIES In the Lab In the Lab 1 month ago NIH PANEL CALLS FOR FEWER, BETTER-PAID POSTDOCS IN BID TO HALT LOSS OF SCIENTISTS TO INDUSTRY In the Lab In the Lab 1 month ago STAT PLUS: CAR-T, RECENTLY USED IN A LUPUS PATIENT, HELPS OTHER AUTOIMMUNE PATIENTS, TOO, IN SMALL STUDY HOSPITALS Hospitals STAT PLUS: NONPROFIT HEALTH SYSTEMS PLUG THEIR STRONG CASH RESERVES AT JPM — A VERY DIFFERENT PITCH THAN THEY MAKE ELSEWHERE By Tara Bannow 6 days ago By Tara Bannow Hospitals Hospitals 6 days ago STAT PLUS: NONPROFIT HEALTH SYSTEMS PLUG THEIR STRONG CASH RESERVES AT JPM — A VERY DIFFERENT PITCH THAN THEY MAKE ELSEWHERE Hospitals Hospitals 1 week ago STAT PLUS: HEATED LAWSUIT BETWEEN ADVENTHEALTH, MULTIPLAN ATTRACTS HOSPITAL LOBBYISTS Hospitals Hospitals 1 week ago STAT PLUS: HOSPITALS TRY A NEW PITCH TO INVESTORS: OTHER WAYS OF MAKING MONEY INSURANCE Insurance STAT PLUS: FIERY MEDPAC MEETING HIGHLIGHTS MASSIVE OVERPAYMENTS IN MEDICARE ADVANTAGE By Bob Herman 6 days ago By Bob Herman Insurance Insurance 6 days ago STAT PLUS: FIERY MEDPAC MEETING HIGHLIGHTS MASSIVE OVERPAYMENTS IN MEDICARE ADVANTAGE Insurance Insurance 1 month ago STAT PLUS: BIDEN ADMINISTRATION ASKS JUDGE TO TOSS OUT HUMANA’S MEDICARE ADVANTAGE AUDIT LAWSUIT Insurance Insurance 1 month ago STAT PLUS: HOT ANTITRUST ENVIRONMENT HANGS OVER CALLED-OFF MERGER BETWEEN CIGNA AND HUMANA PODCASTS The Readout LOUD LIVE! FROM JPM 2024 The Readout LOUD 2023 IN REVIEW, CEO REPORT CARDS, AND A LOOK AT THE YEAR AHEAD The Readout LOUD FTC V. BIOTECH, PFIZER’S KITCHEN SINK, & VERTEX’S FUTURE First Opinion Podcast WHEN DO TESTS HURT MORE THAN HELP? All Podcasts Understand how science, health policy, and medicine shape the world every day Industry Academia Advertising/Communications Agency Advocacy/Non-Profit Banking Biotech Clinical Research Organization Consulting Firm Consumer Health Financial Services (Other) Government Healthcare Payer/Insurance Health Tech Hospital Systems/Provider Law Media Medical Devices Medical Technology Pharmaceuticals Pharmacy/Retail Real Estate Trade Association Technology Venture Capital Privacy Policy Sign up for our morning rounds newsletter Reporting from the frontiers of health and medicine Back to top Company * About * Our Team * Contact Us * Careers * Diversity & Inclusion * Our Awards * Advertise With Us * STAT Brand Studio * Supporters * Licensing Stories Account * STAT+ * Group Subscriptions * FAQ * My Account * Log In * Subscribe More * Events * Newsletters * Reports * App * Podcasts * Community * STAT Trials Pulse * Privacy * Comment Policy * Terms * Do Not Sell my Data * ©2024 STAT * * * * * * * Become a STAT+ subscriber today! Become a STAT+ subscriber today! Unlimited access to essential biotech, medicine, and life sciences journalism Get started Become a STAT+ subscriber today! Become a STAT+ subscriber today! Your go-to source for the latest news and insights on biopharma and the life sciences Get started Become a STAT+ subscriber today! Become a STAT+ subscriber today! Unlimited access to essential biotech, medicine, and life sciences journalism Get started Become a STAT+ subscriber today! Become a STAT+ subscriber today! Your go-to source for the latest news and insights on biopharma and the life sciences Get started STAT NEWS ASKS FOR YOUR CONSENT TO USE YOUR PERSONAL DATA TO: * show_chart Personalised advertising, advertising and content measurement, audience research and services development * perm_identity Personalised content * devices Store and/or access information on a device expand_moreremove Learn more * How can I change my choice? * What if I don't consent? * How does legitimate interest work? * Do I have to consent to everything? Your personal data will be processed and information from your device (cookies, unique identifiers, and other device data) may be stored by, accessed by and shared with 9 TCF vendor(s) and 1 ad partner(s), or used specifically by this site or app. Some vendors may process your personal data on the basis of legitimate interest, which you can object to by managing your options below. Look for a link at the bottom of this page or in our privacy policy where you can withdraw consent. Consent Manage options arrow_back Data preferences MANAGE YOUR DATA You can choose how your personal data is used. Vendors want your permission to do the following: TCF vendors help_outline STORE AND/OR ACCESS INFORMATION ON A DEVICE Cookies, device or similar online identifiers (e.g. login-based identifiers, randomly assigned identifiers, network based identifiers) together with other information (e.g. browser type and information, language, screen size, supported technologies etc.) can be stored or read on your device to recognise it each time it connects to an app or to a website, for one or several of the purposes presented here. View details Consent (8 vendors) USE LIMITED DATA TO SELECT ADVERTISING Advertising presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type or which content you are (or have been) interacting with (for example, to limit the number of times an ad is presented to you). View details Consent (1 vendor)Legitimate interest (1 vendor)help_outline CREATE PROFILES FOR PERSONALISED ADVERTISING Information about your activity on this service (such as forms you submit, content you look at) can be stored and combined with other information about you (for example, information from your previous activity on this service and other websites or apps) or similar users. This is then used to build or improve a profile about you (that might include possible interests and personal aspects). Your profile can be used (also later) to present advertising that appears more relevant based on your possible interests by this and other entities. View details Consent (7 vendors) USE PROFILES TO SELECT PERSONALISED ADVERTISING Advertising presented to you on this service can be based on your advertising profiles, which can reflect your activity on this service or other websites or apps (like the forms you submit, content you look at), possible interests and personal aspects. View details Consent (2 vendors) CREATE PROFILES TO PERSONALISE CONTENT Information about your activity on this service (for instance, forms you submit, non-advertising content you look at) can be stored and combined with other information about you (such as your previous activity on this service or other websites or apps) or similar users. This is then used to build or improve a profile about you (which might for example include possible interests and personal aspects). Your profile can be used (also later) to present content that appears more relevant based on your possible interests, such as by adapting the order in which content is shown to you, so that it is even easier for you to find content that matches your interests. View details Consent (5 vendors) USE PROFILES TO SELECT PERSONALISED CONTENT Content presented to you on this service can be based on your content personalisation profiles, which can reflect your activity on this or other services (for instance, the forms you submit, content you look at), possible interests and personal aspects, such as by adapting the order in which content is shown to you, so that it is even easier for you to find (non-advertising) content that matches your interests. View details Consent (1 vendor) MEASURE ADVERTISING PERFORMANCE Information regarding which advertising is presented to you and how you interact with it can be used to determine how well an advert has worked for you or other users and whether the goals of the advertising were reached. For instance, whether you saw an ad, whether you clicked on it, whether it led you to buy a product or visit a website, etc. This is very helpful to understand the relevance of advertising campaigns. View details Consent (3 vendors)Legitimate interest (3 vendors)help_outline MEASURE CONTENT PERFORMANCE Information regarding which content is presented to you and how you interact with it can be used to determine whether the (non-advertising) content e.g. reached its intended audience and matched your interests. For instance, whether you read an article, watch a video, listen to a podcast or look at a product description, how long you spent on this service and the web pages you visit etc. This is very helpful to understand the relevance of (non-advertising) content that is shown to you. View details Consent (2 vendors)Legitimate interest (1 vendor)help_outline UNDERSTAND AUDIENCES THROUGH STATISTICS OR COMBINATIONS OF DATA FROM DIFFERENT SOURCES Reports can be generated based on the combination of data sets (like user profiles, statistics, market research, analytics data) regarding your interactions and those of other users with advertising or (non-advertising) content to identify common characteristics (for instance, to determine which target audiences are more receptive to an ad campaign or to certain contents). View details Consent (5 vendors)Legitimate interest (2 vendors)help_outline DEVELOP AND IMPROVE SERVICES Information about your activity on this service, such as your interaction with ads or content, can be very helpful to improve products and services and to build new products and services based on user interactions, the type of audience, etc. This specific purpose does not include the development or improvement of user profiles and identifiers. View details Consent (4 vendors)Legitimate interest (3 vendors)help_outline ENSURE SECURITY, PREVENT AND DETECT FRAUD, AND FIX ERRORS help_outline Your data can be used to monitor for and prevent unusual and possibly fraudulent activity (for example, regarding advertising, ad clicks by bots), and ensure systems and processes work properly and securely. It can also be used to correct any problems you, the publisher or the advertiser may encounter in the delivery of content and ads and in your interaction with them. View details DELIVER AND PRESENT ADVERTISING AND CONTENT help_outline Certain information (like an IP address or device capabilities) is used to ensure the technical compatibility of the content or advertising, and to facilitate the transmission of the content or ad to your device. View details MATCH AND COMBINE DATA FROM OTHER DATA SOURCES help_outline Information about your activity on this service may be matched and combined with other information relating to you and originating from various sources (for instance your activity on a separate online service, your use of a loyalty card in-store, or your answers to a survey), in support of the purposes explained in this notice. View details LINK DIFFERENT DEVICES help_outline In support of the purposes explained in this notice, your device might be considered as likely linked to other devices that belong to you or your household (for instance because you are logged in to the same service on both your phone and your computer, or because you may use the same Internet connection on both devices). View details IDENTIFY DEVICES BASED ON INFORMATION TRANSMITTED AUTOMATICALLY help_outline Your device might be distinguished from other devices based on information it automatically sends when accessing the Internet (for instance, the IP address of your Internet connection or the type of browser you are using) in support of the purposes exposed in this notice. View details Vendor preferences Accept all Confirm choices arrow_back Vendor preferences CONFIRM OUR VENDORS Vendors can use your data to provide services. Declining a vendor can stop them from using the data you shared. TCF vendors help_outline SHARETHIS, INC Cookie duration: 390 (days). Data collected and processed: Browsing and interaction data, Users’ profiles, Privacy choices, Probabilistic identifiers, IP addresses, Device characteristics, Device identifiers, Non-precise location data more View details | Privacy policylaunch Consent LOTAME SOLUTIONS, INC Cookie duration: 274 (days). Data collected and processed: Browsing and interaction data, Users’ profiles, Privacy choices, Probabilistic identifiers, Authentication-derived identifiers, IP addresses, Device characteristics, Device identifiers, User-provided data more Cookie duration resets each session. Uses other forms of storage. View details | Privacy policylaunch Consent LIVERAMP Cookie duration: 365 (days). Data collected and processed: Browsing and interaction data, Privacy choices, Authentication-derived identifiers, IP addresses, Device characteristics, Device identifiers, Non-precise location data more Cookie duration resets each session. Uses other forms of storage. View details | Storage details | Privacy policylaunch Consent DYNATA LLC Cookie duration: 365 (days). Data collected and processed: Browsing and interaction data, Users’ profiles, Privacy choices, Authentication-derived identifiers, IP addresses, Device characteristics, Device identifiers, Non-precise location data, User-provided data more Cookie duration resets each session. View details | Storage details | Privacy policylaunch Consent EYEOTA PTE LTD Cookie duration: 365 (days). Data collected and processed: Users’ profiles, Privacy choices, Probabilistic identifiers, IP addresses, Device characteristics, Device identifiers, Non-precise location data more Cookie duration resets each session. View details | Storage details | Privacy policylaunch Consent BOMBORA INC. Cookie duration: 365 (days). Data collected and processed: Browsing and interaction data, Users’ profiles, Authentication-derived identifiers, IP addresses, Device characteristics, Device identifiers, Non-precise location data more Cookie duration resets each session. Uses other forms of storage. View details | Storage details | Privacy policylaunch ConsentLegitimate interesthelp_outline ORACLE ADVERTISING Cookie duration: 180 (days). Data collected and processed: Browsing and interaction data, Users’ profiles, Privacy choices, Authentication-derived identifiers, Device characteristics, Device identifiers, Non-precise location data, User-provided data more Uses other forms of storage. View details | Storage details | Privacy policylaunch Consent GOOGLE ADVERTISING PRODUCTS Cookie duration: 396 (days). Data collected and processed: Browsing and interaction data, Users’ profiles, Privacy choices, Authentication-derived identifiers, IP addresses, Device characteristics, Device identifiers, Non-precise location data, User-provided data more Uses other forms of storage. View details | Storage details | Privacy policylaunch ConsentLegitimate interesthelp_outline ORACLE DATA CLOUD - MOAT Doesn't use cookies. Data collected and processed: IP addresses, Non-precise location data more View details | Privacy policylaunch Legitimate interesthelp_outline Ad partners help_outline ADSTRA Privacy policylaunch Consent Accept all Confirm choices Close Please review our cookie policy We use first- and third-party cookies to customize your experience and display advertising. By continuing to use the site, you agree to our use of cookies. If you want to know more or opt out in whole or in part, please see our Privacy Notice and our Cookie FAQ. Accept No thanks